ISSN (print) 1726-9806     ISSN (online) 1818-474X
No. 2 (2017), ANESTHESIOLOGY
No. 2 (2017)
ANESTHESIOLOGY

Evaluation Effective Low-Volume Cardioplegia By «Custodiol» Solution

Published 24.06.2017
T.A. Istomin
North-Western State Medical University named after I.I. Mechnikov, Saint Petersburg, Russia
https://orcid.org/0000-0001-7725-5499
Iliya S. Kurapeev
North-Western State Medical University named after I.I. Mechnikov, Saint Petersburg, Russia
https://orcid.org/0000-0002-2341-4658
#2017-2
PDF_2017-2_43-49 (Russian)

Keywords

myocardial protection
cardioplegia
cardioplegic solution
Custodiol

How to Cite

1.
Istomin T.A., Kurapeev I.S. Evaluation Effective Low-Volume Cardioplegia By «Custodiol» Solution. Annals of Critical Care. 2017;(2):43-49. doi:10.21320/1818-474X-2017-2-43-49
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver

Download Citation

Endnote/Zotero/Mendeley (RIS) BibTeX

Statistic

Abstract Views: 1599
PDF_2017-2_43-49 (Russian) Downloads: 50
Statistic from 01.07.2024

Language

English Русский

Most reader

Social Networks

Abstract

Objectives. The study presents the results of quality assessment of antiischemic myocardial protection by low-volume method of cardioplegia by Custodiol solution during operations with cardiopulmonary bypass. Material and Methods. The study involved 57 patients who underwent different cardiosurgery operations with cardiopulmonary bypass. The patients were divided into two groups on the basis of the volume of cardioplegic solution. Research group (group 1) consists of 33 patients who were administered Custodiol in low volume limited by 1000 ml. The control group (group 2) consists of 24 patients who were administered standart volume of the solution corresponding to the manufacturer’s instructions: 1 ml per 1 g of myocardial mass during 6–8 minutes. Results. The volume of Custodiol administered per 1 kg of body weight was 12.7 ± 2.0 and 22.7 ± 4 ml and 4.0 ± 1.3 and 6.3 ± 1.9 ml per 1 g of myocardial mass in groups 1 and 2, respectively (p < 0.001). The frequency of catecholamines usage, temporary cardiac pacing and other adverse events with a small-volume cardioplegia technique with Custodiol solution did not differ significantly. The results has indicated that the use of low volume of cardioplegic Custodiol in a single administration manner provides a complete antiischemic protection of the myocardium during the correction of valvular heart disease, including combination with coronary artery bypass grafting. Conclusion. Usage of low volume Custodiol solution method does not increase the need of inotropic and vasopressor usage and pacing time.

PDF_2017-2_43-49 (Russian)

References

  1. Семеновский М.Л., Соколов В.В., Ковалева Е.В. Клиническая оценка эффективности кардиоплегического раствора внутриклеточного типа «Кустодиола» при длительном выключении сердца из кровообращения. Грудная и сердечно-сосудистая хирургия. 1998; 4: 20–23. [Semenovskii M.L., Sokolov V.V., Kovaleva E.V. Klinicceskaya otsenka effektivnosti kardioplegicheskogo rastvora vnutrikletochnogo tipa Kustoiol pri dlitel’nom vyklyuchenii serdtsa iz krovoobrashcheniya. Grudnaya i serdechno-sosudistaya hirurgiya. 1998; 4: 20–23. (In Russ)]
  2. Положий Д.Н. Сравнительная оценка эффективности защиты миокарда с применением раствора Бретшнайдера и кровяной кардиоплегии при хирургической коррекции клапанной патологии и ИБС: Дис. … канд. мед. наук. М., 2013. [Polozhii D.N. Sravnitel’naya otsenka effektivnosti zashchity miokarda s primeneniem rastvora Bretshnaidera i krovyanoi kardioplegii pri khirurgicheskoi korrektsii klapannoi patologii i IBS [dissertation]. Moscow, 2013. (In Russ)]
  3. Edelman J.J.B., Seco M., Dunne B. et al. Custodiol for myo- cardial protection and preservation: a systematic review. Cardiothoracic 2013; 2: 717–728.
  4. Инструкция по медицинскому применению препарата «Кустодиол» [электронный ресурс]. URL: http://кустодиол.рф/php [Instruktsiya po meditsinskomu primeneniyu preparata Kustodiol [Internet]. URL: http://кустодиол.рф/instruction.php (In Russ)]
  5. Лоскутов О.А. Оценка эффективности кардиоплегического раствора Бретшнайдера при аортокоронарном шунтировании. Український журнал екстремальної медицини ім. Г.О. Можаєва. 2013; 14(1): 95–98. [Loskutov O.A. Otsenka effektivnosti kardioplegicheskogo rastvora Bretshnaidera pri aortokoronarnom shuntirovanii. Ukrainskii zhurnal ekstremal’noi meditsiny G.O. Mozhaeva. 2013; 14(1): 95–98. (In Russ)]
  6. Arslan , Sezgin A., Gultekin B. et al. Low-Dose Histidine-Tryptophane-Ketodlutarate for Myocardial Protection. Transplantation Proceeding. 2005; 37: 3219–3222.
  7. Braathen B., Jeppsson А., Schersten H. et al. One single dose of histidine-tryptophan-ketoglutarate solution gives equally good myocardial protection in elective mitral valve surgery as repetitive cold blood cardioplegia: A prospective randomized J. Thorac. Cardiovasc. Surg. 2011; 141(4): 995–1001.
  8. Lueck S., Preusse C.J., Welz A. Clinical relevance of HTK-induced hyponatremia. Ann. Thorac. Surg. 2013; 95(5): 1844– 1845.
  9. Scott D.A., Tung M., Slater R. Perioperative Hemoglobin Trajectory in Adult Cardiac Surgical Patients. J. Extra Corpor. Tech- nol. 2015; 47(3): 167–173.
  10. Пантеева О.Н., Александров Н.Ю., Лебединский К.М. Глубина анестезии и ее стабильность при операциях с использованием искусственного кровообращения. Эфферентная терапия. 2009; 15(3–4): 101–106. [Panteeva O.N., Alexandrov N.U., Lebedinskii K.M. Glubina anestezii i ee its stabil’nost’ pri operatsiyah s ispol’zovaniem iskusstvennogo krovoobrashcheniya. Efferentnaya terapiya. 2009; 15(3–4): 101–106. (In Russ)]
  11. Sanjay P., Srikrishna S.V., Prashanth P. et al. Antegrade versus antegrade with retrograde delivery of cardioplegic solution in myocardial revascularisation. A clinical study in patients with triple vessel coronary artery disease. Ann. Card. Anaesth. 2003; 6(2): 143–148.
  12. Buckberg G.D., Beyersdorf , Kato N.S. Technical considerations and logic of antegrade and retrograde blood cardioplegic delivery. Semin. Thorac. Cardiovasc. Surg. 1993: 5(2): 125–133.
  13. Yilik L., Ozsoyler I., Yakut et al. Passive infusion: a simple delivery method for retrograde cardioplegia. Tex. Heart Inst. J. 2004; 31(4): 392–397.
  14. Трекова Н.А., Аксельрод Б.А., Юдичев И.И. и др. Клинические аспекты динамики лактата крови во время операций на сердце и аорте в условиях искусственного кровообращения. Анестезиология и реаниматология. 2016; 61(5): 324–329. [Trekova N.A., Akselrod B.A., Yudichev I.I. et al. Clinical aspects of the blood lactate dynamics during operations on the heart and the aorta in conditions of cardiopulmonary bypass. Anesteziol. i 2016; 62(5): 26–31. (In Russ)]
  15. Murphy G.S., Hessel E.A. 2nd, Groom R.C. Optimal perfusion during cardiopulmonary bypass: an evidence-based approach. Anesth. Analg. 2009; 108(5): 1394–1417.
  16. Kim T., Park Y.H., Chang Y.E. et al. The effect of cardioplegic solution-induced sodium concentration fluctuation on postoperative seizure in pediatric cardiac patients. Ann. Thorac. Surg. 2011; 91(6): 1943–1948.
  17. Lindner G., Zapletal B., Schwarz Ch. et al. Acute hyponatremia after cardioplegia by histidine-tryptophane-ketoglutarate — a retrospective J. of Cardiothoracic Surgery. 2012; 7: 1–5.
  18. Hensley A. Jr, Gravlee G.P., Martin D.E. A Practical Approach to Cardiac Anesthesia, 5th ed. Philadelphia: Wolters Kluwer Health/Lippincott, Williams & Wilkins, 2012.
  19. Чарная М.А., Дементьева И.И., Морозов Ю.А. и др. Кардиоспецифические биомаркеры в кардиологии и кардиохирургии. Кардиология и сердечно-сосудистая хирургия. 2010; 4: 10–16. [Charhaya M.A., Dement’eva I.I., Morozov Yu.A. et al. Kardiospetsificheskie biomarkery v kardiologii i kardiohirurgii. Kardiologiya i serdechno-sosudistaya 2010; 4: 10–16. (In Russ)]
  20. Задорожная М.П., Разумов В.В. Спорные вопросы эхокардиографического определения массы миокарда левого желудочка и его гипертрофии (Аналитический обзор и собственные наблюдения). Современные проблемы науки и образования. 2015; 6: 216–225. [Zadorozhnaya M.P., Razumov V.V. Spornye voprosy ehokardiograficheskogo opredeleniya massy miokarda levogo zheludochka i ego gipertrofii (Analiticheskii ob- zor i sobstvennye nabludeniya). Sovrenennye problemy nauki i obrazovaniya. 2015; 6: 216–225. (In Russ)]
  21. Ferguson Z.G., Yarborough D.E., Jarvis B.L., Sistino J.J. Evidence-based medicine and myocardial protection — where is the evidence? Perfusion. 2015; 30(5): 415–422.
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Copyright (c) 2017 ANNALS OF CRITICAL CARE